Clinical Trial Investigators Cannot Promote A Drug Prior To Its Approval, FDA Asserts
This article was originally published in The Pink Sheet Daily
Executive Summary
An investigator for Ipsen Biopharm's anti-wrinkling product Dysport touts it as superior to Botox in women's magazines and on the "Today Show."